AtriCure Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Adjusted EPS Results. Also, Needham and JP Morgan Lowered Their Respective Price Targets on the Stock.
AtriCure Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Adjusted EPS Results. Also, Needham and JP Morgan Lowered Their Respective Price Targets on the Stock.
AtriCure公布的第一季度调整后每股收益低于预期后，该公司股价走低。此外，尼德姆和摩根大通下调了各自的股票目标股价。
AtriCure Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Adjusted EPS Results. Also, Needham and JP Morgan Lowered Their Respective Price Targets on the Stock.
AtriCure公布的第一季度调整后每股收益低于预期后，该公司股价走低。此外，尼德姆和摩根大通下调了各自的股票目标股价。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。